NPI: 1659334985 · PHILADELPHIA, PA 19104 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,963 | $5K |
| 2020 | 3,439 | $270K |
| 2021 | 9,933 | $832K |
| 2022 | 7,589 | $839K |
| 2023 | 7,247 | $712K |
| 2024 | 6,442 | $490K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,941 | 2,479 | $3.14M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,195 | 382 | $5K |
| G0008 | Administration of influenza virus vaccine | 21 | 18 | $291.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 2,399 | 225 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 570 | 330 | $0.00 |
| 85048 | 324 | 301 | $0.00 | |
| 82108 | 34 | 33 | $0.00 | |
| 83970 | 221 | 208 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 2,340 | 594 | $0.00 |
| 83540 | 194 | 179 | $0.00 | |
| 84466 | 146 | 136 | $0.00 | |
| 85045 | 82 | 79 | $0.00 | |
| 85041 | 324 | 301 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 75 | 12 | $0.00 |
| A4657 | Syringe, with or without needle, each | 1,982 | 662 | $0.00 |
| 82607 | 39 | 38 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,328 | 292 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 140 | 111 | $0.00 |
| 82728 | 206 | 196 | $0.00 | |
| 83550 | 13 | 13 | $0.00 | |
| 82746 | 39 | 38 | $0.00 |